Correction: Precision synbiotic intervention with 2'-fucosyllactose and infant-derived Bifidobacterium modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial
Ke Chen, Xi Zhang, Shanshan Jin, Jiayi Zhong, Haixia Chen, Genquan Yue, Yonghui Cheng, Rufeng Peng, Ziji Fang, Feitong Liu, Zerong Lu, Lingling Zhao, Ruibiao Hu, Xiaohan Tao, Qilin He, Changqi Liu · 2026
Read Correction: Precision synbiotic intervention with 2'-fucosyllactose and infant-derived Bifidobacterium modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial by Ke Chen, Xi Zhang, Shanshan Jin, Jiayi Zhong, Haixia Chen, Genquan Yue, Yonghui Cheng, Rufeng Peng, Ziji Fang, Feitong Liu, Zerong Lu, Lingling Zhao, Ruibiao Hu, Xiaohan Tao, Qilin He, Changqi Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624849.txt.
Description
e-blind, placebo-controlled, three-arm trial, 390 healthy toddlers were randomized (1:1:1) to receive (1) synbiotic (2′-FL 1.0 g/day + B. infantis R0033 1.5 × 109 CFU + B. bifidum R0071 1.5 × 109 CFU);” A correction has been made to the Section 2, Section 2.4, paragraph one: “All eligible children were randomly assigned to the HPG, IG or CG.
Catalog record
| CREATOR | Ke Chen, Xi Zhang, Shanshan Jin, Jiayi Zhong, Haixia Chen, Genquan Yue, Yonghui Cheng, Rufeng Peng, Ziji Fang, Feitong Liu, Zerong Lu, Lingling Zhao, Ruibiao Hu, Xiaohan Tao, Qilin He, Changqi Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |